Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jefferies Financial
JEF
5
Amazon
AMZN
US Stock MarketDetailed Quotes
VERA Vera Therapeutics
- 24.000
- +0.590+2.52%
Close Apr 29 16:00 ET
- 24.000
- 0.0000.00%
Post 20:01 ET
1.53BMarket Cap-8.73P/E (TTM)
24.030High23.040Low717.37KVolume23.280Open23.410Pre Close17.10MTurnover1.42%Turnover RatioLossP/E (Static)63.77MShares51.61052wk High2.65P/B1.21BFloat Cap18.53052wk Low--Dividend TTM50.56MShs Float51.610Historical High--Div YieldTTM4.23%Amplitude5.200Historical Low23.836Avg Price1Lot Size
About Vera Therapeutics Company
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
Company Profile
SymbolVERA
Company NameVera Therapeutics
Listing DateMay 14, 2021
Issue Price11.00
Founded2016
CEODr. Marshall Fordyce, M.D.
MarketNASDAQ
Employees112
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 1200
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-770-0077
Websitehttp://www.veratx.com
Company Executives
- Name
- Position
- Salary
- Dr. Marshall Fordyce, M.D.
- President, Chief Executive Officer and Director
- 5.65M
- Joseph Young
- Senior Vice President, Finance and Chief Accounting Officer
- --
- William D. Turner
- Chief Development Officer
- --
- Sean P. Grant
- Chief Financial Officer
- --
- Jason S. Carter
- Chief Legal Officer
- --
- David L. Johnson, C.P.A.
- Chief Operating Officer
- --
- Dr. Robert M. Brenner,M.D.
- Chief Medical Officer
- 4.46M
- Dr. Michael M. Morrissey, PhD
- Chairman of the Board
- 471.59K
- Kimball Hall
- Independent Director
- 432.59K
- Christy J. Oliger
- Independent Director
- 775.40K
- Scott W. Morrison
- Independent Director
- 446.59K
- Patrick G. Enright, M.B.A.
- Independent Director
- 438.59K
- Dr. Maha Katabi, PhD
- Independent Director
- 436.59K
- Dr. Beth C. Seidenberg,M.D.
- Independent Director
- 436.59K
- Dr. Andrew Cheng, M.D.,PhD
- Independent Director
- 437.59K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
